{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:26:15Z","timestamp":1782624375113,"version":"3.54.5"},"reference-count":127,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:00:00Z","timestamp":1665878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR21H300001"],"award-info":[{"award-number":["LR21H300001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872798"],"award-info":[{"award-number":["81872798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1909208"],"award-info":[{"award-number":["U1909208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leading Talent of the \u2018Ten Thousand Plan\u2019\u2014National High-Level Talents Special Support Plan of China"},{"name":"Fundamental Research Fund of Central University","award":["2018QNA7023"],"award-info":[{"award-number":["2018QNA7023"]}]},{"name":"Key R&D Program of Zhejiang Province","award":["2020C03010"],"award-info":[{"award-number":["2020C03010"]}]},{"name":"National Key R&D Program of China Synthetic Biology Research","award":["2019YFA0905900"],"award-info":[{"award-number":["2019YFA0905900"]}]},{"name":"\u2018Double Top-Class\u2019 University","award":["181201*194232101"],"award-info":[{"award-number":["181201*194232101"]}]},{"name":"Space Exploration Breeding Grant of Qian Xuesen Lab","award":["TKTSPY-2020-04-03"],"award-info":[{"award-number":["TKTSPY-2020-04-03"]}]},{"name":"Scientific Research Grant of Ningbo University","award":["215\u2013432000282"],"award-info":[{"award-number":["215\u2013432000282"]}]},{"name":"Ningbo Top Talent Proj","award":["215\u2013432094250"],"award-info":[{"award-number":["215\u2013432094250"]}]},{"name":"Shenzhen Municipal Government grant","award":["JCYJ20170413113448742"],"award-info":[{"award-number":["JCYJ20170413113448742"]}]},{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","award":["2017B030314083"],"award-info":[{"award-number":["2017B030314083"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Westlake Laboratory"},{"name":"Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare"},{"name":"Alibaba Cloud"},{"name":"Information Technology Center of Zhejiang University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The efficacy and safety of drugs are widely known to be determined by their interactions with multiple molecules of pharmacological importance, and it is therefore essential to systematically depict the molecular atlas and pharma-information of studied drugs. However, our understanding of such information is neither comprehensive nor precise, which necessitates the construction of a new database providing a network containing a large number of drugs and their interacting molecules. Here, a new database describing the molecular atlas and pharma-information of drugs (DrugMAP) was therefore constructed. It provides a comprehensive list of interacting molecules for\u00a0&amp;gt;30 000 drugs\/drug candidates, gives the differential expression patterns for\u00a0&amp;gt;5000 interacting molecules among different disease sites, ADME (absorption, distribution, metabolism and excretion)-relevant organs and physiological tissues, and weaves a comprehensive and precise network containing\u00a0&amp;gt;200 000 interactions among drugs and molecules. With the great efforts made to clarify the complex mechanism underlying drug pharmacokinetics and pharmacodynamics and rapidly emerging interests in artificial intelligence (AI)-based network analyses, DrugMAP is expected to become an indispensable supplement to existing databases to facilitate drug discovery. It is now fully and freely accessible at: https:\/\/idrblab.org\/drugmap\/<\/jats:p>","DOI":"10.1093\/nar\/gkac813","type":"journal-article","created":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T09:46:40Z","timestamp":1665913600000},"page":"D1288-D1299","source":"Crossref","is-referenced-by-count":84,"title":["DrugMAP: molecular atlas and pharma-information\u00a0of all drugs"],"prefix":"10.1093","volume":"51","author":[{"given":"Fengcheng","family":"Li","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"},{"name":"Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare , Hangzhou \u00a0330110,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yin","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkun","family":"Lu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-2975","authenticated-orcid":false,"given":"Minjie","family":"Mou","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaorong","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare , Hangzhou \u00a0330110,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare , Hangzhou \u00a0330110,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, Tsinghua Shenzhen International Graduate School, Tsinghua University , Shenzhen \u00a0518055,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University , Ningbo \u00a0315211,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chu","sequence":"additional","affiliation":[{"name":"Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University , Ningbo \u00a0315211,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Dai","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjun","family":"Hou","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zeng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5473-8022","authenticated-orcid":false,"given":"Yuzong","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, Tsinghua Shenzhen International Graduate School, Tsinghua University , Shenzhen \u00a0518055,\u00a0 China"},{"name":"Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University , Ningbo \u00a0315211,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-0053","authenticated-orcid":false,"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou \u00a0310058,\u00a0 China"},{"name":"Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare , Hangzhou \u00a0330110,\u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,16]]},"reference":[{"key":"2023010804340118500_B1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/gim.2017.156","article-title":"Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics","volume":"20","author":"Santos","year":"2018","journal-title":"Genet. Med."},{"key":"2023010804340118500_B2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","article-title":"Pharmacogenomics","volume":"394","author":"Roden","year":"2019","journal-title":"Lancet"},{"key":"2023010804340118500_B3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-pharmtox-010818-021909","article-title":"Assessment of pharmacokinetic drug\u2013drug interactions in humans: in vivo probe substrates for drug metabolism and drug transport revisited","volume":"59","author":"Fuhr","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2023010804340118500_B4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccell.2020.04.006","article-title":"Functional genomics for cancer drug target discovery","volume":"38","author":"Haley","year":"2020","journal-title":"Cancer Cell"},{"key":"2023010804340118500_B5","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.drup.2021.100788","article-title":"Modulating undruggable targets to overcome cancer therapy resistance","volume":"60","author":"Passirani","year":"2022","journal-title":"Drug Resist. Updat."},{"key":"2023010804340118500_B6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/pr.120.019554","article-title":"RNA drugs and RNA targets for small molecules: principles, progress, and challenges","volume":"72","author":"Yu","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"2023010804340118500_B7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd4461","article-title":"What do drug transporters really do?","volume":"14","author":"Nigam","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023010804340118500_B8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.addr.2016.06.004","article-title":"Recent advance in the pharmacogenomics of human solute carrier transporters (SLCs) in drug disposition","volume":"116","author":"Zhou","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"2023010804340118500_B9","doi-asserted-by":"crossref","first-page":"113638","DOI":"10.1016\/j.bcp.2019.113638","article-title":"Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics","volume":"169","author":"Ning","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"2023010804340118500_B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pharmthera.2019.05.011","article-title":"Aldehyde oxidase and its role as a drug metabolizing enzyme","volume":"201","author":"Dalvie","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"2023010804340118500_B11","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.apsb.2022.03.009","article-title":"Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development","volume":"12","author":"Lai","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"2023010804340118500_B12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/toxsci\/kfaa114","article-title":"Contribution of pulmonary CYP-mediated bioactivation of naphthalene to airway epithelial injury in the lung","volume":"177","author":"Kovalchuk","year":"2020","journal-title":"Toxicol. Sci."},{"key":"2023010804340118500_B13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/toxsci\/kfz225","article-title":"Proximal tubular vacuolization and hypersensitivity to drug-induced nephrotoxicity in male mice with decreased expression of the NADPH-cytochrome P450 reductase","volume":"173","author":"Ding","year":"2020","journal-title":"Toxicol. Sci."},{"key":"2023010804340118500_B14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.tips.2016.08.003","article-title":"Impact of membrane drug transporters on resistance to small-molecule tyrosine kinase inhibitors","volume":"37","author":"Neul","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"2023010804340118500_B15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.apsb.2018.12.002","article-title":"Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"2023010804340118500_B16","doi-asserted-by":"crossref","first-page":"bbaa430","DOI":"10.1093\/bib\/bbaa430","article-title":"An end-to-end heterogeneous graph representation learning-based framework for drug\u2013target interaction prediction","volume":"22","author":"Peng","year":"2021","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semcancer.2020.02.004","article-title":"Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias\u2014a missed opportunity","volume":"68","author":"Perez","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"2023010804340118500_B18","doi-asserted-by":"crossref","first-page":"bbab397","DOI":"10.1093\/bib\/bbab397","article-title":"RNA\u2013RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection","volume":"23","author":"Zhang","year":"2021","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/bph.14957","article-title":"Protective effect of cilastatin against diclofenac-induced nephrotoxicity through interaction with diclofenac acyl glucuronide via organic anion transporters","volume":"177","author":"Huo","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"2023010804340118500_B20","doi-asserted-by":"crossref","first-page":"348ra397","DOI":"10.1126\/scitranslmed.aaf3124","article-title":"Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2023010804340118500_B21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.mam.2012.10.012","article-title":"Transporter biology in drug approval: regulatory aspects","volume":"34","author":"Maeda","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"2023010804340118500_B22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/cpt.1174","article-title":"Molecular modeling of drug\u2013transporter interactions\u2014an international transporter consortium perspective","volume":"104","author":"Schlessinger","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010804340118500_B23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acschemneuro.1c00694","article-title":"Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram","volume":"13","author":"Xue","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804340118500_B24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","article-title":"A genetics-led approach defines the drug target landscape of 30 immune-related traits","volume":"51","author":"Fang","year":"2019","journal-title":"Nat. Genet."},{"key":"2023010804340118500_B25","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/bph.15017","article-title":"Timing in drug absorption and disposition: the past, present, and future of chronopharmacokinetics","volume":"177","author":"Bicker","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"2023010804340118500_B26","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.drup.2021.100789","article-title":"Molecular modeling strategies of cancer multidrug resistance","volume":"59","author":"Yalcin-Ozkat","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"2023010804340118500_B27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2016.01.009","article-title":"The role of glucuronidation in drug resistance","volume":"159","author":"Mazerska","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"2023010804340118500_B28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"2023010804340118500_B29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/dmd.118.081356","article-title":"Drug transporters in xenobiotic disposition and pharmacokinetic prediction","volume":"46","author":"Mao","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"2023010804340118500_B30","doi-asserted-by":"crossref","first-page":"D1233","DOI":"10.1093\/nar\/gkaa755","article-title":"INTEDE: interactome of drug-metabolizing enzymes","volume":"49","author":"Yin","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B31","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"Guney","year":"2016","journal-title":"Nat. Commun."},{"key":"2023010804340118500_B32","doi-asserted-by":"crossref","first-page":"119342","DOI":"10.1016\/j.lfs.2021.119342","article-title":"Pharmacology of lacosamide: from its molecular mechanisms and pharmacokinetics to future therapeutic applications","volume":"275","author":"Carona","year":"2021","journal-title":"Life Sci."},{"key":"2023010804340118500_B33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrs.2019.04.031","article-title":"ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches","volume":"144","author":"Leandro","year":"2019","journal-title":"Pharmacol. Res."},{"key":"2023010804340118500_B34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13020-020-00351-9","article-title":"The involvement of human organic anion transporting polypeptides (OATPs) in drug\u2013herb\/food interactions","volume":"15","author":"Ali","year":"2020","journal-title":"Chin. Med."},{"key":"2023010804340118500_B35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-pharmtox-010919-023324","article-title":"Big data and artificial intelligence modeling for drug discovery","volume":"60","author":"Zhu","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2023010804340118500_B36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/bib\/bby127","article-title":"ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies","volume":"21","author":"Tang","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41467-019-13807-w","article-title":"De novo generation of hit-like molecules from gene expression signatures using artificial intelligence","volume":"11","author":"Mendez-Lucio","year":"2020","journal-title":"Nat. Commun."},{"key":"2023010804340118500_B38","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3390\/cancers12113369","article-title":"The expression profiles of ADME genes in human cancers and their associations with clinical outcomes","volume":"12","author":"Hu","year":"2020","journal-title":"Cancers"},{"key":"2023010804340118500_B39","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"2023010804340118500_B40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/cpt.1750","article-title":"Broad-spectrum profiling of drug safety via learning complex network","volume":"107","author":"Liu","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010804340118500_B41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cels.2016.03.001","article-title":"Metabolic network prediction of drug side effects","volume":"2","author":"Shaked","year":"2016","journal-title":"Cell Syst."},{"key":"2023010804340118500_B42","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.xphs.2020.10.009","article-title":"Impaired transport activity of human organic anion transporters (OATs) and organic anion transporting polypeptides (OATPs) by wnt inhibitors","volume":"110","author":"Ali","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"2023010804340118500_B43","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B44","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug\u2013gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B45","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B46","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B47","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the drugbank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B48","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/clpt.2012.44","article-title":"The UCSF-FDA transportal: a public drug transporter database","volume":"92","author":"Morrissey","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010804340118500_B50","doi-asserted-by":"crossref","first-page":"D1417","DOI":"10.1093\/nar\/gkab1013","article-title":"VARIDT 2.0: structural variability of drug transporter","volume":"50","author":"Fu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B51","doi-asserted-by":"crossref","first-page":"D498","DOI":"10.1093\/nar\/gkaa1025","article-title":"BRENDA, the ELIXIR core data resource in 2021: new developments and updates","volume":"49","author":"Chang","year":"(2021)","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B52","doi-asserted-by":"crossref","first-page":"D552","DOI":"10.1093\/nar\/gkaa945","article-title":"KinaseMD: kinase mutations and drug response database","volume":"49","author":"Hu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B53","doi-asserted-by":"crossref","first-page":"D911","DOI":"10.1093\/nar\/gkx899","article-title":"ADReCS-Target: target profiles for aiding drug safety research and application","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.tibs.2019.04.004","article-title":"Drug\u2013target association kinetics in drug discovery","volume":"44","author":"IJzerman","year":"2019","journal-title":"Trends Biochem. Sci"},{"key":"2023010804340118500_B55","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1038\/s41467-021-27137-3","article-title":"A unified drug\u2013target interaction prediction framework based on knowledge graph and recommendation system","volume":"12","author":"Ye","year":"2021","journal-title":"Nat. Commun."},{"key":"2023010804340118500_B56","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","article-title":"Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B57","first-page":"D1031","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B58","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0140-6736(19)31205-X","article-title":"ICD-11","volume":"393","author":"The Lancet","year":"2019","journal-title":"Lancet"},{"key":"2023010804340118500_B59","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B60","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/jama.2017.15764","article-title":"Polypharmacy","volume":"318","author":"Onder","year":"2017","journal-title":"JAMA"},{"key":"2023010804340118500_B61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aaz9906","article-title":"The activities of drug inactive ingredients on biological targets","volume":"369","author":"Pottel","year":"2020","journal-title":"Science"},{"key":"2023010804340118500_B62","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cpt.1434","article-title":"Pharmacodynamic drug\u2013drug interactions","volume":"105","author":"Niu","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010804340118500_B63","doi-asserted-by":"crossref","first-page":"D1042","DOI":"10.1093\/nar\/gkz779","article-title":"VARIDT 1.0: variability of drug transporter database","volume":"48","author":"Yin","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B64","doi-asserted-by":"crossref","first-page":"bbac160","DOI":"10.1093\/bib\/bbac160","article-title":"Biological activities of drug inactive ingredients","volume":"23","author":"Zhang","year":"2022","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B65","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.apsb.2019.02.005","article-title":"Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)","volume":"9","author":"Huo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"2023010804340118500_B66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/bib\/bby130","article-title":"Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs","volume":"21","author":"Li","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B67","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/j.celrep.2020.02.094","article-title":"Machine learning uncovers food\u2013 and excipient\u2013drug interactions","volume":"30","author":"Reker","year":"2020","journal-title":"Cell Rep."},{"key":"2023010804340118500_B68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cmet.2019.07.005","article-title":"Drug metabolism as a community effort","volume":"30","author":"Hitchings","year":"2019","journal-title":"Cell Metab."},{"key":"2023010804340118500_B69","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.xphs.2017.04.056","article-title":"Understanding the interplay between uptake and efflux transporters within in vitro systems in defining hepatocellular drug concentrations","volume":"106","author":"Cantrill","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"2023010804340118500_B70","doi-asserted-by":"crossref","first-page":"108271","DOI":"10.1016\/j.pharmthera.2022.108271","article-title":"The next frontier in ADME science: predicting transporter-based drug disposition, tissue concentrations and drug\u2013drug interactions in humans","volume":"24","author":"Storelli","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"2023010804340118500_B71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023010804340118500_B72","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/dmd.119.086744","article-title":"Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities","volume":"47","author":"Zhang","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"2023010804340118500_B73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/17425247.2016.1214565","article-title":"Transporter effects on cell permeability in drug delivery","volume":"14","author":"Mandal","year":"2017","journal-title":"Expert Opin. Drug Deliv"},{"key":"2023010804340118500_B74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"Cesar-Razquin","year":"2015","journal-title":"Cell"},{"key":"2023010804340118500_B75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.117.242552","article-title":"Correlation between apparent substrate affinity and OCT2 transport turnover","volume":"362","author":"Severance","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2023010804340118500_B76","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ajps.2018.11.006","article-title":"Organic anion transporters also mediate the drug\u2013drug interaction between imipenem and cilastatin","volume":"15","author":"Zhu","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"2023010804340118500_B77","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/cpt.1435","article-title":"Clinical studies on drug\u2013drug interactions involving metabolism and transport: methodology, pitfalls, and interpretation","volume":"105","author":"Tornio","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010804340118500_B78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cpt.1481","article-title":"Opportunities and challenges of using big data to detect drug\u2013drug interaction risk","volume":"106","author":"Quinney","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"2023010804340118500_B79","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1073\/pnas.1820799116","article-title":"From single drug targets to synergistic network pharmacology in ischemic stroke","volume":"116","author":"Casas","year":"2019","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023010804340118500_B80","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/bib\/bbaa257","article-title":"Biological network analysis with deep learning","volume":"22","author":"Muzio","year":"2021","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B81","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1124\/dmd.115.064576","article-title":"Target-site drug metabolism and transport","volume":"43","author":"Foti","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"2023010804340118500_B82","doi-asserted-by":"crossref","first-page":"352ra109","DOI":"10.1126\/scitranslmed.aaf9074","article-title":"ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: a rationale for safer glucocorticoid replacement therapy","volume":"8","author":"Nixon","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2023010804340118500_B83","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B84","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/bioinformatics\/bty1041","article-title":"An accurate and powerful method for copy number variation detection","volume":"35","author":"Xiao","year":"2019","journal-title":"Bioinformatics"},{"key":"2023010804340118500_B85","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B86","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41591-019-0638-5","article-title":"Chromatin regulators mediate anthracycline sensitivity in breast cancer","volume":"25","author":"Seoane","year":"2019","journal-title":"Nat. Med."},{"key":"2023010804340118500_B87","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/bib\/bbz049","article-title":"Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data","volume":"21","author":"Yang","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-022-02677-z","article-title":"Refining colorectal cancer classification and clinical stratification through a single-cell atlas","volume":"23","author":"Khaliq","year":"2022","journal-title":"Genome Biol."},{"key":"2023010804340118500_B89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13073-021-00956-1","article-title":"De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity","volume":"13","author":"Moosavi","year":"2021","journal-title":"Genome Med"},{"key":"2023010804340118500_B90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix genechip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2023010804340118500_B91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41596-021-00636-9","article-title":"Optimization of metabolomic data processing using NOREVA","volume":"17","author":"Fu","year":"2022","journal-title":"Nat. Protoc."},{"key":"2023010804340118500_B92","doi-asserted-by":"crossref","first-page":"W436","DOI":"10.1093\/nar\/gkaa258","article-title":"NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data","volume":"48","author":"Yang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B93","doi-asserted-by":"crossref","first-page":"W162","DOI":"10.1093\/nar\/gkx449","article-title":"NOREVA: normalization and evaluation of MS-based metabolomics data","volume":"45","author":"Li","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B94","doi-asserted-by":"crossref","first-page":"bbaa105","DOI":"10.1093\/bib\/bbaa105","article-title":"MetaFS: performance assessment of biomarker discovery in metaproteomics","volume":"22","author":"Tang","year":"2021","journal-title":"Brief. Bioinform"},{"key":"2023010804340118500_B95","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygeno.2005.04.008","article-title":"Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues","volume":"86","author":"Ge","year":"2005","journal-title":"Genomics"},{"key":"2023010804340118500_B96","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with alphafold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"2023010804340118500_B97","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/ci00060a003","article-title":"Chemical abstracts service chemical registry system. 11. Substance-related statistics: update and additions","volume":"28","author":"Stobaugh","year":"1988","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"2023010804340118500_B98","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B99","doi-asserted-by":"crossref","first-page":"k1452","DOI":"10.1136\/bmj.k1452","article-title":"How to avoid common problems when using clinicaltrials.gov in research: 10 issues to consider","volume":"361","author":"Tse","year":"2018","journal-title":"BMJ"},{"key":"2023010804340118500_B100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/M15-2658","article-title":"ClinicalTrials.gov and drugs@fda: a comparison of results reporting for new drug approval trials","volume":"165","author":"Schwartz","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"2023010804340118500_B101","doi-asserted-by":"crossref","first-page":"D1214","DOI":"10.1093\/nar\/gkv1031","article-title":"ChEBI in 2016: improved services and an expanding collection of metabolites","volume":"44","author":"Hastings","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-021-00517-z","article-title":"InChI version 1.06: now more than 99.99% reliable","volume":"13","author":"Goodman","year":"2021","journal-title":"J Cheminform"},{"key":"2023010804340118500_B103","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B104","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the National Center for Biotechnology Information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B105","doi-asserted-by":"crossref","first-page":"D1086","DOI":"10.1093\/nar\/gku1127","article-title":"Type material in the NCBI taxonomy database","volume":"43","author":"Federhen","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B106","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41594-021-00586-6","article-title":"Synergies between the protein data bank and the community","volume":"28","author":"Berman","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2023010804340118500_B107","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"UniProt Consortium","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B108","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13321-020-00447-2","article-title":"DTiGEMS+: drug\u2013target interaction prediction using graph embedding, graph mining, and similarity-based techniques","volume":"12","author":"Thafar","year":"2020","journal-title":"J. Cheminform."},{"key":"2023010804340118500_B109","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41467-017-00680-8","article-title":"A network integration approach for drug\u2013target interaction prediction and computational drug repositioning from heterogeneous information","volume":"8","author":"Luo","year":"2017","journal-title":"Nat. Commun."},{"key":"2023010804340118500_B110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/bioinformatics\/bty543","article-title":"NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug\u2013target interactions","volume":"35","author":"Wan","year":"2019","journal-title":"Bioinformatics"},{"key":"2023010804340118500_B111","doi-asserted-by":"crossref","first-page":"e26726","DOI":"10.7554\/eLife.26726","article-title":"Systematic integration of biomedical knowledge prioritizes drugs for repurposing","volume":"6","author":"Himmelstein","year":"2017","journal-title":"Elife"},{"key":"2023010804340118500_B112","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jgg.2017.04.005","article-title":"ADMETNet: the knowledge base of pharmacokinetics and toxicology network","volume":"44","author":"Xu","year":"2017","journal-title":"J. Genet. Genomics"},{"key":"2023010804340118500_B113","doi-asserted-by":"crossref","first-page":"105465","DOI":"10.1016\/j.compbiomed.2022.105465","article-title":"PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods","volume":"145","author":"Xia","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"2023010804340118500_B114","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/bib\/bbz137","article-title":"A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies","volume":"21","author":"Yang","year":"2020","journal-title":"Brief. Bioinform"},{"key":"2023010804340118500_B115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape automation: empowering workflow-based network analysis","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biol."},{"key":"2023010804340118500_B116","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/acschemneuro.8b00729","article-title":"How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin A enantiomers based on molecular dynamics","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804340118500_B117","doi-asserted-by":"crossref","first-page":"bbac040","DOI":"10.1093\/bib\/bbac040","article-title":"POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability","volume":"23","author":"Li","year":"(2022)","journal-title":"Brief. Bioinform"},{"key":"2023010804340118500_B118","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acschemneuro.8b00059","article-title":"Exploring the binding mechanism of metabotropic glutamate receptor 5 negative allosteric modulators in clinical trials by molecular dynamics simulations","volume":"9","author":"Fu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804340118500_B119","doi-asserted-by":"crossref","first-page":"104023","DOI":"10.1016\/j.jprot.2020.104023","article-title":"MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis","volume":"232","author":"Yang","year":"2021","journal-title":"J. Proteomics"},{"key":"2023010804340118500_B120","doi-asserted-by":"crossref","first-page":"D560","DOI":"10.1093\/nar\/gkab926","article-title":"SYNBIP: synthetic binding proteins for research, diagnosis and therapy","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804340118500_B121","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/bib\/bbz081","article-title":"Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning","volume":"21","author":"Hong","year":"2020","journal-title":"Brief. Bioinform"},{"key":"2023010804340118500_B122","doi-asserted-by":"crossref","first-page":"bbac253","DOI":"10.1093\/bib\/bbac253","article-title":"ConSIG: consistent discovery of molecular signature from OMIC data","volume":"23","author":"Li","year":"2022","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B123","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/bib\/bbz120","article-title":"Convolutional neural network-based annotation of bacterial type IV secretion system effectors with enhanced accuracy and reduced false discovery","volume":"21","author":"Hong","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2023010804340118500_B124","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1039\/C7CP07869B","article-title":"Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder","volume":"20","author":"Xue","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"2023010804340118500_B125","doi-asserted-by":"crossref","first-page":"105825","DOI":"10.1016\/j.compbiomed.2022.105825","article-title":"REGLIV: molecular regulation data of diverse living systems facilitating current multiomics research","volume":"148","author":"Zhang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"2023010804340118500_B126","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acschemneuro.7b00490","article-title":"What contributes to serotonin\u2013norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation","volume":"9","author":"Xue","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804340118500_B127","doi-asserted-by":"crossref","first-page":"bbab138","DOI":"10.1093\/bib\/bbab138","article-title":"Pharmacometabonomics: data processing and statistical analysis","volume":"22","author":"Fu","year":"2021","journal-title":"Brief. Bioinform"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/51\/D1\/D1288\/48441582\/gkac813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/51\/D1\/D1288\/48441582\/gkac813.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T04:39:00Z","timestamp":1673152740000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/51\/D1\/D1288\/6761740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,16]]},"references-count":127,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2022,10,16]]},"published-print":{"date-parts":[[2023,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkac813","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,6]]},"published":{"date-parts":[[2022,10,16]]}}}